https://www.selleckchem.com/pr....oducts/CP-673451.htm
d isavuconazole prophylaxis per protocol. The rate of breakthrough candidemia was 3.1% and there were no invasive mold infections. Our data support the utility of isavuconazole for antifungal prophylaxis after HCT. Peripheral blood stem cells (PBSC) have been increasingly used for allogeneic hematopoietic cell transplantation compared to bone marrow stem cells. Currently, the National Marrow Donor Program (NMDP) policy recommends 5 days of daily filgrastim followed by either 1 or 2 days of apheresis for unrelated donors, depending on